Asset sale Pending Sponsor buyer

Nuvo Pharmaceuticals (Ireland) DAC acquisition of Cumberland FDA-approved commercial products and related assets

US$100m consideration

Announced 22 Apr 2026

Advisers

Cumberland FDA-approved commercial products and related assets

Target

Financial adviser
Legal adviser
Baker Donelson (as Baker, Donelson, Bearman, Caldwell & Berkowitz, P.C.)
Fairness opinion

Nuvo Pharmaceuticals (Ireland) DAC

Acquirer

Legal adviser
Target
Cumberland FDA-approved commercial products and related assets
Acquirer
Nuvo Pharmaceuticals (Ireland) DAC
Sponsor
Apotex
Seller
Cumberland Pharmaceuticals
Target based in
United States
Buyer based in
Ireland
Seller based in
United States
Sector
Pharma

In the league tables

Similar deals

All pharma deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.